J9273 HCPCS code: Injection, tisotumab vedotin-tftv, 1 mg
J9273 is the HCPCS Level II code for injection, tisotumab vedotin-tftv, 1 mg. In 2024 Medicare paid an average of $138.53 per service for J9273 across 15,330 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 200 per day on outpatient hospital claims. Medicare volume rose 65% from 2022 to 2024 (9,304 to 15,330 services). In 2024, about 58 clinicians billed Medicare for J9273 for 34 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2022-04-01 |
| Last action effective | 2022-04-01 |
Who bills J9273 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 58 |
| Medicare beneficiaries | 34 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9273, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 9,304 | 22 | $152.48 | $121.54 |
| 2023 | 19,830 | 35 | $147.89 | $117.81 |
| 2024 | 15,330 | 34 | $173.31 | $138.53 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 200 | Prescribing Information |
| practitioner claims | 200 | Prescribing Information |
What changed for J9273
- 2022-04-01: J9273 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9273?
J9273 is the HCPCS Level II code for injection, tisotumab vedotin-tftv, 1 mg. Short descriptor: "Inj tisotu vedotin-tftv, 1mg".
How much does Medicare pay for J9273?
In 2024, the average Medicare payment was $138.53 per service (average allowed $173.31).
Does Medicare cover J9273?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9273 can be billed per day?
200 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related J92 codes
- J9200 — Injection, floxuridine, 500 mg
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 — Goserelin acetate implant, per 3.6 mg
- J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 — Injection, mogamulizumab-kpkc, 1 mg
- J9205 — Injection, irinotecan liposome, 1 mg
- J9206 — Injection, irinotecan, 20 mg
- J9207 — Injection, ixabepilone, 1 mg
- J9208 — Injection, ifosfamide, 1 gram
- J9209 — Injection, mesna, 200 mg
- J9210 — Injection, emapalumab-lzsg, 1 mg
- J9211 — Injection, idarubicin hydrochloride, 5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9273
- Watch J9273 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9273
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.